A small-molecule inhibitor of integrin α2β1 introduces a new strategy for antithrombotic therapyJarmo Käpylä, Jyrki Heino, Marika Ojala et al.|Thrombosis and Haemostasis|2009Cited by 38
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in miceNicole R. Bonetti, Jürg H. Beer, Lisa Pasterk et al.|Thrombosis Research|2023Cited by 6